Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
about
Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on EfficacyIntranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial.Effect of migraine attacks on paracetamol absorption.Non-oral formulations of triptans and their use in acute migraine.New Prescriptions for Migraine in the Emergency Department: Treating a common affliction and presenting symptom.Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.Cutaneous allodynia and migraine: another view.Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications.Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardee.Migraine and gastroparesis from a gastroenterologist's perspective.Delayed absorption of many (paracetamol, aspirin, other NSAIDs and zolmitriptan) but not all (sumatriptan, rizatriptan) drugs during migraine attacks and most likely normal gastric emptying outside attacks. A review.Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.Biopharmaceutical aspects of tolfenamic acid.Tolfenamic acid and migraine--aspects on prostaglandins and leukotrienes.
P2860
Q33698292-FEA5D47A-6177-484B-B31B-7DD77C97923AQ34308609-81934962-4BA4-49DD-AB66-B656A40E385BQ34622186-2FA6AE12-C723-4F03-92D3-FDD893C0F9AEQ36133893-80B1CD32-B1E7-4357-8998-8CAB7AC038EBQ36284515-EE0834E2-769C-4F81-BA40-8F14BE0F796AQ36373560-B79A9AC0-6952-4578-AA7E-A1218D0EC532Q37263436-9A89C9C0-7A3B-497B-B9D1-4A23F51AB329Q37398431-6F9C6CA6-BD24-49A0-A95E-18B3B9E8D5ACQ37986145-1A1FD281-50A3-4EED-85C5-94674F381876Q38110593-181028A6-97DC-4A02-A8E6-E0C106E16A03Q38872695-11DB4979-589D-482E-AB1C-75216AC917B3Q39251453-926E64BF-13FD-46B8-A7BE-FDDBE2214927Q39356297-5E037614-68D6-475A-8916-FD8817EBDDF4Q40566300-D1211D7A-6E23-4F7F-91A2-8E180B65E050Q40566360-79125167-C039-4878-9673-96F86F65D18F
P2860
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
description
1984 nî lūn-bûn
@nan
1984 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@ast
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@en
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@nl
type
label
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@ast
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@en
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@nl
prefLabel
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@ast
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@en
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@nl
P2860
P1476
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
@en
P2093
Neuvonen PJ
P2860
P356
10.1111/J.1365-2125.1984.TB05001.X
P407
P577
1984-01-01T00:00:00Z